3 assets in Beta-Thalassemia Intermedia

Therapeutic assets addressing Beta-Thalassemia Intermedia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Mitapivat Beta-Thalassemia Intermedia	Agios Pharmaceuticals, Inc.	P3	B (60)
Exerenibart Beta-Thalassemia Intermedia	Regeneron Pharmaceuticals	P2	CCC (53)
Benserazide Beta-Thalassemia Intermedia	Phoenicia BioScience	P1/2	CCC (48)